Literature DB >> 31772983

Clinical Implementation of a Proton Dose Verification System Utilizing a GPU Accelerated Monte Carlo Engine.

Chris Beltran1, H Wan Chan Tseung1, Kurt E Augustine2, Martin Bues2, Daniel W Mundy1, Timothy J Walsh3, Michael G Herman1, Nadia N Laack1.   

Abstract

PURPOSE: To develop a clinical infrastructure that allows for routine Monte Carlo dose calculation verification of spot scanning proton treatment plans and includes a simple biological model to aid in normal tissue protection.
MATERIALS AND METHODS: A graphical processing unit accelerated Monte Carlo dose engine was used as the calculation engine for dose verification on spot scanning proton plans. An infrastructure was built around this engine that allows for seamless exporting of treatment plans from the treatment planning system and importing of dose distribution from the Monte Carlo calculation via DICOM (digital imaging and communications in medicine). An easy-to-use Web-based interface was developed so that the application could be run from any computer. In addition to the standard relative biological effectiveness = 1.1 for proton therapy, a simple linear equation dependent on dose-weighted linear energy transfer was included. This was used to help detect possible high biological dose in critical structures.
RESULTS: More than 270 patients were treated at our proton center in the first year of operation. Because most plans underwent multiple iterations before final approval, more than 1000 plans have been run through the system from multiple users with minimal downtime. The average time from plan export to importing of the Monte Carlo doses was less than 15 minutes. Treatment plans have been modified based on the nominal Monte Carlo dose or the biological dose.
CONCLUSION: Monte Carlo dose calculation verification of spot scanning proton treatment plans is feasible in a clinical environment. The 3-dimensional dose verification, particularly near heterogeneities, has resulted in plan modifications. The biological dose data provides actionable feedback for end of range effects, especially in pediatric patients. © Copyright 2016 International Journal of Particle Therapy.

Entities:  

Keywords:  Monte Carlo; dose verification; proton therapy

Year:  2016        PMID: 31772983      PMCID: PMC6871619          DOI: 10.14338/IJPT-16-00011.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  19 in total

1.  Range uncertainty in proton therapy due to variable biological effectiveness.

Authors:  Alejandro Carabe; Maryam Moteabbed; Nicolas Depauw; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2012-02-14       Impact factor: 3.609

2.  Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy.

Authors:  Jillian R Gunther; Mariko Sato; Murali Chintagumpala; Leena Ketonen; Jeremy Y Jones; Pamela K Allen; Arnold C Paulino; M Fatih Okcu; Jack M Su; Jeffrey Weinberg; Nicholas S Boehling; Soumen Khatua; Adekunle Adesina; Robert Dauser; William E Whitehead; Anita Mahajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-16       Impact factor: 7.038

3.  The prediction of output factors for spread-out proton Bragg peak fields in clinical practice.

Authors:  Hanne M Kooy; Stanley J Rosenthal; Martijn Engelsman; Alejandro Mazal; Roelf L Slopsema; Harald Paganetti; Jacob B Flanz
Journal:  Phys Med Biol       Date:  2005-12-06       Impact factor: 3.609

4.  A procedure for calculation of monitor units for passively scattered proton radiotherapy beams.

Authors:  Narayan Sahoo; X Ronald Zhu; Bijan Arjomandy; George Ciangaru; MingFwu Lii; Richard Amos; Richard Wu; Michael T Gillin
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

5.  Range and modulation dependencies for proton beam dose per monitor unit calculations.

Authors:  Wen C Hsi; Andries N Schreuder; Michael F Moyers; Chris E Allgower; Jonathan B Farr; Anthony E Mascia
Journal:  Med Phys       Date:  2009-02       Impact factor: 4.071

6.  Independent dose calculations for commissioning, quality assurance and dose reconstruction of PBS proton therapy.

Authors:  G Meier; R Besson; A Nanz; S Safai; A J Lomax
Journal:  Phys Med Biol       Date:  2015-03-17       Impact factor: 3.609

7.  TOPAS: an innovative proton Monte Carlo platform for research and clinical applications.

Authors:  J Perl; J Shin; J Schumann; B Faddegon; H Paganetti
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

8.  A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.

Authors:  Minna Wedenberg; Bengt K Lind; Björn Hårdemark
Journal:  Acta Oncol       Date:  2012-08-22       Impact factor: 4.089

9.  Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy.

Authors:  Hok Seum Wan Chan Tseung; Jiasen Ma; Cole R Kreofsky; Daniel J Ma; Chris Beltran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-06       Impact factor: 7.038

10.  Verification of monitor unit calculations for non-IMRT clinical radiotherapy: report of AAPM Task Group 114.

Authors:  Robin L Stern; Robert Heaton; Martin W Fraser; S Murty Goddu; Thomas H Kirby; Kwok Leung Lam; Andrea Molineu; Timothy C Zhu
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

View more
  9 in total

1.  Dose calculation accuracy in particle therapy: Comparing carbon ions with protons.

Authors:  Sirinya Ruangchan; Hugo Palmans; Barbara Knäusl; Dietmar Georg; Monika Clausen
Journal:  Med Phys       Date:  2021-09-23       Impact factor: 4.506

2.  Biological Effectiveness of Ion Beam for In Vitro Cell Irradiations.

Authors:  Heng Li
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  Automated Monte-Carlo re-calculation of proton therapy plans using Geant4/Gate: implementation and comparison to plan-specific quality assurance measurements.

Authors:  Adam H Aitkenhead; Peter Sitch; Jenny C Richardson; Carla Winterhalter; Imran Patel; Ranald I Mackay
Journal:  Br J Radiol       Date:  2020-07-29       Impact factor: 3.039

4.  Automation of Monte Carlo-based treatment plan verification for proton therapy.

Authors:  Maduka Kaluarachchi; Vadim Moskvin; Fakhriddin Pirlepesov; Lydia J Wilson; Fang Xie; Austin M Faught
Journal:  J Appl Clin Med Phys       Date:  2020-05-26       Impact factor: 2.102

5.  NRG Oncology Survey of Monte Carlo Dose Calculation Use in US Proton Therapy Centers.

Authors:  Liyong Lin; Paige A Taylor; Jiajian Shen; Jatinder Saini; Minglei Kang; Charles B Simone; Jeffrey D Bradley; Zuofeng Li; Ying Xiao
Journal:  Int J Part Ther       Date:  2021-05-25

6.  How can we consider variable RBE and LETd prediction during clinical practice? A pediatric case report at the Normandy Proton Therapy Centre using an independent dose engine.

Authors:  Stewart Mein; Benedikt Kopp; Anthony Vela; Pauline Dutheil; Paul Lesueur; Dinu Stefan; Jürgen Debus; Thomas Haberer; Amir Abdollahi; Andrea Mairani; Thomas Tessonnier
Journal:  Radiat Oncol       Date:  2022-02-04       Impact factor: 3.481

7.  New School Technology Meets Old School Technique: Intensity Modulated Proton Therapy and Laparoscopic Pelvic Sling Facilitate Safe and Efficacious Treatment of Pelvic Sarcoma.

Authors:  Hunter C Gits; Eric J Dozois; Matthew T Houdek; Thanh P Ho; Scott H Okuno; Rachael M Guenzel; Laura A McGrath; Alan J Kraling; Jedediah E Johnson; Scott C Lester
Journal:  Adv Radiat Oncol       Date:  2022-06-28

8.  RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy.

Authors:  Chunbo Liu; Julie A Bradley; Dandan Zheng; Raymond B Mailhot Vega; Chris J Beltran; Nancy Mendenhall; Xiaoying Liang
Journal:  J Appl Clin Med Phys       Date:  2022-01-21       Impact factor: 2.102

9.  Fast MCsquare-Based Independent Dose Verification Platform for Pencil Beam Scanning Proton Therapy.

Authors:  Chunbo Liu; Meng Wei Ho; Jiyeon Park; Wen Chien Hsi; Xiaoying Liang; Zuofeng Li; Yuntao Song; Hansheng Feng; Yawei Zhang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.